Status:

UNKNOWN

Effect of Covid-19 Epidemic on Primary PCI in Patients With STEMI

Lead Sponsor:

Beijing Friendship Hospital

Conditions:

STEMI

Eligibility:

All Genders

Brief Summary

The epidemic of covid-19 has spread all over the world and has a great impact on people's health and life. It is necessary to study the treatment of STEMI patients in the real world under the influenc...

Detailed Description

The epidemic of covid-19 has spread all over the world and has a great impact on people's health and life. The patients' prognosis is poor because the epidemic situation runs on medical resources, del...

Eligibility Criteria

Inclusion

  • Continuous inclusion of patients with definite diagnosis of acute ST segment elevation myocardial infarction and emergency PCI intervention.

Exclusion

  • Febrile patients, patients with severe infection,
  • ST segment elevation myocardial infarction during hospitalization,
  • Patients who could not cooperate with each other.

Key Trial Info

Start Date :

January 24 2019

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

July 24 2021

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT04427735

Start Date

January 24 2019

End Date

July 24 2021

Last Update

June 11 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Beijing Friendship Hospital, Capital Medical University

Beijing, China